Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending April 15, 2022 - Holidays.

Drug Industry TRx: -2.6% w/w; +9.2% y/y

Vascepa
TRx 69,653; -4.2% (-3,019) w/w; -16.9% y/y
NRx 32,340; -5.1% (-1,756) w/w; -16.6% y/y
Ref 37,312; -3.3% (-1,263) w/w; -17.2% y/y

Lovaza (Generic & Brand)
TRx 61,486; -1.8% (-1,124) w/w; +1.1% y/y
NRx 30,783; -4.2% (-1,351) w/w; +1.6% y/y
Ref 30,703; +0.7% (+227) w/w; +0.6% y/y

Generic Vascepa
TRx 31,001; +3.4% (+1,033) w/w; As % of total V: 30.8%
NRx 16,487; +4.0% (+633) w/w; As % of total V: 33.8%
Ref 14,514; +2.8% (+400) w/w; As % of total V: 29.0%

Generic Vascepa by Manufacturer
Hikma - TRx 6,351; (-510) w/w; Generic share 20.5%; Total V share 6.3%
Reddy - TRx 13,524; (+657) w/w; Generic share 43.6%; Total V share 13.4%
Apotex - TRx 11,127; (+887) w/w; Generic share 35.9%; Total V share 11.1%

Vascepa + Generic Vascepa
TRx 100,654; -1.9% (-1,986) w/w; +8.3% y/y
NRx 48,828; -2.2% (-1,123) w/w; +11.3% y/y
Ref 51,826; -1.6% (-863) w/w; +5.6% y/y